About Arvaya Healthcare Limited
Data last updated: 26 September 2026
Arvaya Healthcare Limited is a public limited company based in Gmc, Assam, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 26 March 1985, the company has been in operation for over 41 years.
Registered with ROC Guwahati under CIN L86100AS1985PLC002323. Listed on BSE: 524723.
Capital: an authorised share capital of ₹200 Cr and a paid-up capital of ₹48.02 Cr. Formerly known as Bijoy Hans Limited. It is led by directors including Kaushal Uttam Shah and Rahul Ravindra Mayur.
Last AGM: 25 August 2025. Financial statements filed for year ended 31 March 2025. Office: Gmc, Assam.
The net worth stands at ₹57.99 Cr (up 1542.78% YoY). Total assets are valued at ₹60.51 Cr (up 1614.16% YoY).
The company is associated with 1 brand - Bijoy Hans Limited.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bijoyhans.net.
-
EmailLocked
-
TelephoneLocked
-
WebsiteLocked
-
Social MediaLocked
-
Registered AddressNirvana Co Working Spaces Mezzanine Floor, Itag Plaza Abc G S Road Guwahati, Gmc, Assam, India – 781005
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Arvaya Healthcare Limited
Arvaya Healthcare Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L86100AS1985PLC002323, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L86100AS1985PLC002323 | Current |
| L51909AS1985PLC002323 | Previous |
| U51909AS1985PTC002323 | Previous |
Associated Brands with Arvaya Healthcare Limited
Arvaya Healthcare Limited operates one associated brand: Bijoy Hans Limited. These brands represent Arvaya Healthcare Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical formulations manufacturing and related services in Guwahati, India. | bijoyhans.net |
Business Activity of Arvaya Healthcare Limited
Arvaya Healthcare Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details for Arvaya Healthcare Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Board of Directors of Arvaya Healthcare Limited
Arvaya Healthcare Limited is currently managed by 6 directors, with 18 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kaushal Uttam Shah | Managing Director | 26 May 2025 | 1 Years 4 Months | Current |
| Rahul Ravindra Mayur | Director | 28 Jul 2025 | 1 Years 1 Months | Current |
| Salil Sriram Shetty | Director | 13 Aug 2024 | 2 Years 1 Months | Current |
|
Brijesh Jugalkishor Biyani
Also directs:
Arvaya Healthcare Limited, Malu Medico Private Limited
|
Director | 28 Jul 2025 | 1 Years 1 Months | Current |
|
Manali Aditya Pandit
Also directs:
Arvaya Healthcare Limited
|
Director | 31 Jan 2026 | 0 Years 7 Months | Current |
|
Bidari Kotresh Anilkumar
Also directs:
Arvaya Healthcare Limited, Hubli Secure Multi Speciality Hospital Llp, Defib Institute Of Health Solutions Llp and 5 more
|
Additional Director | 04 Jul 2026 | 0 Years 2 Months | Current |
Financials of Arvaya Healthcare Limited FY 2025-26 filings available
Arvaya Healthcare Limited reported revenue of ₹- (down 100% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 0.00 | 0.28 | 0.28 | 0.30 | 0.33 | 0.40 | 0.49 |
| Revenue growth | +448.0% | -60.9% | -21.0% | +28.6% | -6.0% | -6.9% | +12.5% |
| EBITDA | (1.37) | 0.03 | (0.36) | (0.51) | (0.30) | (0.27) | (0.23) |
| EBITDA margin | - | +10.7% | -128.6% | -170.0% | -90.9% | -67.5% | -46.9% |
| Profit before tax | (1.20) | 0.19 | (0.12) | (0.44) | (0.18) | (0.10) | (0.04) |
| Net profit | (1.20) | (0.43) | (0.26) | (0.44) | (0.18) | (0.10) | (0.04) |
| Net profit margin | - | -153.6% | -92.9% | -146.7% | -54.6% | -25.0% | -8.2% |
| EPS (₹) | (1.18) | 0.45 | (0.39) | (1.48) | (0.63) | (0.30) | (0.18) |
| Balance sheet | |||||||
| Total assets | 60.51 | 3.53 | 3.45 | 3.59 | 3.95 | 4.14 | 4.23 |
| Net worth | 57.99 | 3.53 | 3.39 | 3.51 | 3.95 | 4.14 | 4.23 |
| Total debt | 2.52 | 0.00 | 0.06 | 0.08 | 0.00 | 0.00 | 0.00 |
| Cash & bank | 0.02 | 2.71 | 1.63 | 1.62 | 1.91 | 2.28 | 2.29 |
| Net working capital | (0.26) | 2.93 | 1.82 | 1.80 | 2.76 | 2.76 | 2.98 |
| Cash flow | |||||||
| Cash from operations | (7.89) | 0.22 | (0.29) | (0.26) | (0.37) | (0.01) | (0.07) |
| Cash from investing | (2.33) | 0.92 | 0.32 | (0.11) | 0.00 | 0.00 | (0.01) |
| Cash from financing | 7.53 | (0.06) | (0.02) | 0.08 | 0.00 | 0.00 | (0.02) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.13 | 0.06 |
| Revenue growth (YoY) | +9997.0% | +9997.0% | +9997.0% | +9997.0% | +9997.0% | +9997.0% | +85.7% | -14.3% |
| Other income | 0.06 | 0.07 | 0.05 | 0.02 | 0.03 | 0.05 | 0.61 | 0.04 |
| Total expenses | 0.90 | 0.70 | 0.21 | 0.33 | 0.29 | 0.19 | 0.20 | 0.23 |
| EBITDA | (0.80) | (0.70) | (0.21) | (0.33) | (0.29) | (0.19) | (0.07) | (0.17) |
| EBITDA margin | -800.0% | - | - | - | - | - | -53.8% | -283.3% |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Interest | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| Profit before tax | (0.88) | (0.63) | (0.16) | (0.31) | (0.26) | (0.15) | 0.53 | (0.14) |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.00 | 0.00 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.13 | 0.06 |
| Revenue growth (YoY) | +9997.0% | +9997.0% | +9997.0% | +9997.0% | +9997.0% | +9997.0% | +85.7% | -14.3% |
| Other income | 0.06 | 0.07 | 0.05 | 0.02 | 0.03 | 0.05 | 0.61 | 0.04 |
| Total expenses | 0.90 | 0.70 | 0.21 | 0.33 | 0.29 | 0.19 | 0.20 | 0.23 |
| EBITDA | (0.80) | (0.70) | (0.21) | (0.33) | (0.29) | (0.19) | (0.07) | (0.17) |
| EBITDA margin | -800.0% | - | - | - | - | - | -53.8% | -283.3% |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Interest | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| Profit before tax | (0.88) | (0.63) | (0.16) | (0.31) | (0.26) | (0.15) | 0.53 | (0.14) |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.00 | 0.00 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.28 | 0.28 | 0.30 | 0.33 | 0.40 | 0.49 |
| Revenue growth | +448.0% | -60.9% | -21.0% | +28.6% | -6.0% | -6.9% | +12.5% |
| Other income | 0.17 | 0.19 | 0.30 | 0.14 | 0.15 | 0.21 | 0.24 |
| Total expenses | 1.37 | 0.25 | 0.64 | 0.81 | 0.63 | 0.67 | 0.72 |
| Employee cost | 0.00 | 0.16 | 0.16 | 0.18 | 0.17 | 0.17 | 0.17 |
| EBITDA | (1.37) | 0.03 | (0.36) | (0.51) | (0.30) | (0.27) | (0.23) |
| EBITDA margin | - | +10.7% | -128.6% | -170.0% | -90.9% | -67.5% | -46.9% |
| Depreciation | 0.00 | 0.02 | 0.05 | 0.06 | 0.03 | 0.04 | 0.05 |
| Interest | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Profit before tax | (1.20) | 0.19 | (0.12) | (0.44) | (0.18) | (0.10) | (0.04) |
| Tax | 0.00 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net profit | (1.20) | (0.43) | (0.26) | (0.44) | (0.18) | (0.10) | (0.04) |
| Net profit margin | - | -153.6% | -92.9% | -146.7% | -54.6% | -25.0% | -8.2% |
| EPS (₹) | (1.18) | 0.45 | (0.39) | (1.48) | (0.63) | (0.30) | (0.18) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 48.02 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
| Reserves & surplus | 9.97 | 0.53 | 0.39 | 0.51 | 0.95 | 1.14 | 1.23 |
| Shareholders' funds (net worth) | 57.99 | 3.53 | 3.39 | 3.51 | 3.95 | 4.14 | 4.23 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unsecured loans | 2.52 | 0.00 | 0.06 | 0.08 | 0.00 | 0.00 | 0.00 |
| Total debt | 2.52 | 0.00 | 0.06 | 0.08 | 0.00 | 0.00 | 0.00 |
| Total liabilities | 60.51 | 3.53 | 3.45 | 3.59 | 3.95 | 4.14 | 4.23 |
| Assets | |||||||
| Gross block | 0.00 | 0.00 | 1.37 | 1.68 | 1.64 | 1.64 | 1.63 |
| Net block | 0.00 | 0.00 | 0.40 | 0.76 | 0.71 | 0.74 | 0.77 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 60.78 | 0.13 | 0.38 | 0.20 | 0.14 | 0.05 | 0.05 |
| Inventories | 0.00 | 0.00 | 0.05 | 0.04 | 0.07 | 0.10 | 0.05 |
| Sundry debtors | 0.00 | 0.00 | 0.08 | 0.09 | 0.08 | 0.13 | 0.17 |
| Cash & bank balances | 0.02 | 2.71 | 1.63 | 1.62 | 1.91 | 2.28 | 2.29 |
| Loans & advances | 7.57 | 0.28 | 0.10 | 0.09 | 0.74 | 0.28 | 0.51 |
| Total current assets | 7.59 | 2.99 | 1.86 | 1.84 | 2.80 | 2.79 | 3.02 |
| Total current liabilities | 7.85 | 0.06 | 0.04 | 0.04 | 0.04 | 0.03 | 0.04 |
| Net working capital | (0.26) | 2.93 | 1.82 | 1.80 | 2.76 | 2.76 | 2.98 |
| Total assets | 60.51 | 3.53 | 3.45 | 3.59 | 3.95 | 4.14 | 4.23 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 2.71 | 1.63 | 1.62 | 1.91 | 2.28 | 2.29 | 2.40 |
| Net cash from operating activities | (7.89) | 0.22 | (0.29) | (0.26) | (0.37) | (0.01) | (0.07) |
| Net cash from investing activities | (2.33) | 0.92 | 0.32 | (0.11) | 0.00 | 0.00 | (0.01) |
| Net cash from financing activities | 7.53 | (0.06) | (0.02) | 0.08 | 0.00 | 0.00 | (0.02) |
| Net change in cash | (2.69) | 1.08 | 0.01 | (0.29) | (0.37) | (0.02) | (0.10) |
| Closing cash | 0.02 | 2.71 | 1.63 | 1.62 | 1.91 | 2.28 | 2.29 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +9997.0% | 0.0% | -6.7% | -9.1% | -17.5% | -18.4% | +22.5% |
| EBITDA growth | - | +9998.0% | +29.4% | -70.0% | -11.1% | -17.4% | +4.2% |
| PBT growth | - | +9998.0% | +72.7% | -144.4% | -80.0% | -150.0% | +42.9% |
| Net income growth | -179.1% | -65.4% | +40.9% | -144.4% | -80.0% | -150.0% | +42.9% |
| Revenue CAGR (3Y) | -100.0% | -5.3% | -11.2% | -15.1% | -6.2% | -3.1% | -28.3% |
| EBITDA CAGR (3Y) | +39.0% | - | +10.1% | +30.4% | +7.7% | 0.0% | -5.2% |
| Profitability & leverage | |||||||
| Net income margin | - | +46.4% | -42.9% | -146.7% | -54.6% | -25.0% | -8.2% |
| Return on capital employed | - | -10.9% | -7.1% | -11.4% | -4.7% | -2.2% | -1.2% |
| Return on net worth | - | -12.1% | -7.5% | -11.8% | -4.7% | -2.2% | -1.2% |
| Debt / equity | - | 0.01 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 |
| Long-term debt / equity | - | 0.01 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 |
| Interest cover | 0.00 | 100.00 | -2.44 | -1.75 | 0.00 | 0.00 | 0.00 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 0.41 | 0.18 | 0.18 | 0.20 | 0.24 | 0.30 |
| Inventory turnover | - | 11.20 | 6.22 | 5.45 | 3.88 | 5.33 | 8.17 |
| Debtors turnover | - | 7.00 | 3.29 | 3.53 | 3.14 | 2.67 | 3.63 |
| EPS (₹) | (1.18) | 0.45 | (0.39) | (1.48) | (0.63) | (0.30) | (0.18) |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 11.76 | 11.31 | 11.70 | 13.18 | 13.80 | 14.10 |
Charges & Borrowings Arvaya Healthcare Limited
Arvaya Healthcare Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Arvaya Healthcare Limited
View historical data on people associated with Arvaya Healthcare Limited, including employment history and EPFO contributions.
Employee and EPFO history for Arvaya Healthcare Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Arvaya Healthcare Limited
GST registrations and filing compliance for Arvaya Healthcare Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Arvaya Healthcare Limited
Credit ratings, litigation, and regulatory alerts for Arvaya Healthcare Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Arvaya Healthcare Limited
MSME payment history for Arvaya Healthcare Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Arvaya Healthcare Limited
Corporate group structure for Arvaya Healthcare Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Arvaya Healthcare Limited
MCA filings and documents for Arvaya Healthcare Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Arvaya Healthcare Limited
Frequently Asked Questions about Arvaya Healthcare Limited
Arvaya Healthcare Limited is an active public limited company in the pharma sector based in Gmc, Assam, India. It was incorporated on 26 March 1985 (41+ years old) and is registered under CIN L86100AS1985PLC002323. Listed on BSE: 524723.
The current directors of Arvaya Healthcare Limited are:
- Kaushal Uttam Shah - Managing Director
- Rahul Ravindra Mayur - Director
- Salil Sriram Shetty - Director
- Brijesh Jugalkishor Biyani - Director
- Manali Aditya Pandit - Director
- Bidari Kotresh Anilkumar - Additional Director
The primary industry of Arvaya Healthcare Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Yes. Arvaya Healthcare Limited is listed on BSE with code 524723.
Arvaya Healthcare Limited can be reached at the registered office: Nirvana Co Working Spaces Mezzanine Floor, Itag Plaza Abc G S Road Guwahati, Gmc, Assam, India – 781005, or through the website bijoyhans.net.
The authorised capital is ₹200 Cr, and the paid-up capital is ₹48.02 Cr.